Ted W. Love - 27 Sep 2022 Form 4 Insider Report for Global Blood Therapeutics, Inc.

Role: President and CEO, Director
Signature: /s/ Miguel Carrillo, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 27 Sep 2022
Net transactions value: +$299,972
Form type: 4
Filing time: 29 Sep 2022, 20:45:13 UTC
Previous filing: 06 Sep 2022
Next filing: 06 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GBT	Common Stock	Gift	$0	-221,200	-27%	$0.000000	593,327	09 Sep 2022	Direct
transaction	GBT	Common Stock	Gift	$0	-35,300	-5.9%	$0.000000	558,027	13 Sep 2022	Direct
transaction	GBT	Common Stock	Gift	$0	+17,650	+17%	$0.000000	119,650	13 Sep 2022	By Trust 1
transaction	GBT	Common Stock	Gift	$0	+17,650	+17%	$0.000000	119,650	13 Sep 2022	By Trust 2
transaction	GBT	Common Stock	Options Exercise	$299,972	+18,291	+3.3%	$16.40^*	576,318	27 Sep 2022	Direct
holding	GBT	Common Stock						102,000	27 Sep 2022	By Trust 3
holding	GBT	Common Stock						2,500	27 Sep 2022	By Daughter
holding	GBT	Common Stock						2,500	27 Sep 2022	By Daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GBT	Stock Option (Right to Buy)	Options Exercise	$0	-18,291	-14%	$0.000000	114,515	27 Sep 2022	Common Stock	18,291	$16.40	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares of Common Stock underlying the option vested in equal quarterly installments over 16 quarters from January 17, 2017 through January 17, 2021.